| Health / Medical Topics |
Topical Sirolimus
A topical formulation containing the macrolide sirolimus (rapamycin), which is produced by the organism Streptomyces hygroscopicus, with potential anti-proliferative activity. Upon application of topical sirolimus, this agent migrates into the skin and is internalized by the affected cells. In turn, sirolimus binds to the immunophilin FK binding protein-12 (FKBP-12) and forms a sirolimus:FKBP-12 complex. This complex binds to and inhibits the activity of the serine/threonine kinase mammalian target of rapamycin (mTOR). It also decreases the production of vascular endothelial growth factor (VEGF) and results in the suppression of cellular proliferation. (NCI Thesaurus)
YOU MAY ALSO LIKE
The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue…
A topical formulation consisting of a polyvinylidene fluoride (PVDF) polymer resin containing the macrolide sirolimus (rapamycin), produced by the organism Streptomyces hygroscopicus,…
Natural or synthetic compounds or mixtures that are applied to body surfaces such as the skin, mouth, vagina, lips, nose, ears or…
A powder spray intended for administration to the skin.
A powder intended for administration to a body surface.
A topical gel containing a cell permeable hydrophilic piperidine nitroxide with potential radioprotective and antioxidant activity. As a stable, free radical compound,…
